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Introduction
This report, funded jointly by the Maine Office of Attorney General and the Office of Behavioral 
Health, provides an overview of statistics regarding suspected and confirmed fatal and nonfatal 
drug overdoses in Maine during the month of February, 2021. Data for the report werecollected 
at the Office of Chief Medical Examiner and as part of the Maine NaloxoneDistribution 
Initiative. This report is the second in a series of monthly reports to be producedwithin about 
two weeks of the end of the month, designed to improve transparency andtimeliness regarding 
the Maine’s epidemic of substance use morbidity and mortality. Year-to-date numbers will 
be updated with each new monthly report, as cases are finalized, and theiroverdose status is 
confirmed or ruled out. The totals are expected to shift as this evolutionoccurs. In addition, 
due to the smaller sample size in each month, we expect totals to fluctuatedue to the effects of 
random variation. These monthly reports will be posted on the Maine drug data hub:  
https://mainedrugdata.org
A “drug death” is confirmed when one or more drugs are mentioned on the death certificate as a 
cause or significant contributing factor for the death. Most drug-induced fatalities are accidents 
related primarily to drug lethality, the unique vulnerability of the drug user, such as underlying 
medical conditions, and the particular circumstances surrounding that drug use during that 
moment. Although there are medical, psychosocial, or public policy interventions that can affect 
individual vulnerability and circumstances, the lethality of the drug or drug combination is 
rarely amenable to policy interventions.
A “suspected” drug fatality is identified by physiological signs of overdose as well as physical 
signs at the scene and witness information. In order for an overdose to be “confirmed,” the 
medical examiner must have issued a final death certificate which includes the names of the 
specific drugs. Comprehensive forensic toxicology testing must also be done, which includes a 
minimum of two toxicology tests, one to screen for drugs present, and another that will quantify 
the levels of drugs in the decedent’s system. All cases receive a thorough external examination. 
In some cases a complete autopsy is also done. Additional data, such as medical records and 
police incident reports are also collected. Most cases are completed within one month.
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Monthly reporting of overdose totals will bring attention to the often dramatic shifts in totals 
that can occur from month to month. Yet, these fluctuations are common with small numbers, 
and will over time tend toward an average. Whereas the overall number of overdose deaths is 
a critical indicator of individual and societal stress, this metric itself can be quite resistant to 
public policy interventions due to its complexity. Overdose fatalities occur because of multiple 
unique and interacting factors, as mentioned above. For that reason, these reports will develop 
ways to monitor components that can be directly affected by specific public health education 
and harm reduction interventions. For example, we will report the number that had access to 
naloxone, and future reports will document the number who were alone while using.
Fatal Overdoses
Overview
The February 2021 total of 45 fatal drug overdoses consists of 27 confirmed drug deaths and 18 
suspected drug deaths. Figure 1 shows the considerable monthly fluctuation over the past year. 
Although the 2020 average is 42, the range extends from 34 to 53. The January 2021 number of 
fatal drug overdoses is currently 54 confirmed and one suspected. Three additional overdoses 
were suspected in January (see January report), but were confirmed as due to different causes of 
death.
Figure 1. Number of suspected and confirmed fatal overdoses by month
Table 1 shows the frequency distribution of deaths at the county level. The February 2021 totals 
can be compared either to the percent of the census population on the left or the percent of all 
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Maine drug deaths for 2020, also on the left. Caution must be exercised with these small county 
totals. They are likely to fluctuate randomly, without any significant statistical meaning. In 
general, the cumulative percentages for January–February in most counties accord with both 
the 2020 patterns and the census distribution. Cumberland and York are lower than their share 
of the population, and Kennebec and Penobscot are higher.















Androscoggin 8  51  (10%)  8  (14%)  5  (11%)  13  (13%)
Aroostook 5  17  (3%)  1  (2%)  2  (4%)  3  (3%)
Cumberland 22  98  (19%)  10  (18%)  9  (20%)  19  (19%)
Franklin 2  8  (2%)  0  (0%)  2  (4%)  2  (2%)
Hancock 4  13  (3%)  2  (4%)  3  (7%)  5  (5%)
Kennebec 9  48  (10%)  6  (11%)  6  (13%)  12  (12%)
Knox 3  17  (3%)  0  (0%)  0  (0%)  0  (0%)
Lincoln 3  9  (2%)  3  (5%)  1  (2%)  4  (4%)
Oxford 4  14  (3%)  3  (5%)  4  (9%)  7 (7%)
Penobscot 11  94  (19%)  7  (13%)  5  (11%)  12  (12%)
Piscataquis 1  10  (2%)  1  (2%)  0  (0%)  1  (1%)
Sagadahoc 3  7  (1%)  1  (2%)  1  (2%)  2  (2%)
Somerset 4  13  (3%)  1  (2%)  2  (4%)  3  (3%)
Waldo 3  9  (2%)  2  (4%)  1  (2%)  3  (3%)
Washington 2  20  (4%)  2  (4%)  1  (2%)  3  (3%)
York 15  75  (15%)  8  (15%)  3  (7%)  11  (11%)
Table 2 displays the age and gender composition of the monthly fatal overdose population. The 
larger number of males in 2021 at 66% is slightly lower than most of Maine’s drug death periods 
in the past, but can be expected to trend toward the 2020 average of 71%. The cumulative age 
distribution in 2021 is nearly identical to 2020, and is clustered in the two middle categories, 
from 18–39 and 40–59. There are no decedents that were under 18, and only 10% over 60.
Table 2. Decedent characteristics among suspected and confirmed overdoses
Jan–Dec 2020  
Est. N=503
January 2021  
Est. N=55
February 2021  
Est. N=45
Cumulative 
Jan–Feb 2021  
Est. N=100
Males  356  (71%)  34  (62%)  32  (71%)  66  (66%)
Under 18  1  (<1%)  0  (0%)  0  (0%)  0 (0%) 
18–39  213  (42%)  20  (36%)  22  (49%)  42  (42%)
40–59  235  (47%)  30  (55%)   18  (40%)  48  (48%)
60+  52  (10%)  5  (9%)  5  (11%)  10  (10%)
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Table 3 reports some of the basic incident patterns. Similar to 2020, in January and February 
2021, both EMS and police responded to most fatal overdoses, 79%. Law enforcement is more 
likely to respond to a scene alone than EMS. The overwhelming majority of January and 
February drug overdoses, 93%, were ruled as accidental manner of death. Unfortunately, 
many victims (39%) had already died before first responders arrived, so resuscitation was 
attempted in 61%. Naloxone was administered to 28% of the victims in 2021, which is nearly 
half (46%) of those who were still alive when first responders arrived. Most naloxone doses 
were administered by EMS personnel, 79%, with some doses being given by law enforcement or 
bystanders or a combination. Naloxone is not given in all cases; for example, non-opioid drugs 
would not respond to naloxone. Although most overdose cases have bystanders present at the 
scene, the details about who was present at the time of the overdose are usually unclear.








Jan–Feb 2021  
Est. N=100
EMS or law enforcement response
EMS response alone  29  (6%)  2  (4%)  2  (4%)  6  (6%)
Law enforcement response alone  108  (21%)  11  (20%)  8 (18%)  19  (19%)
Both EMS and law enforcement  361  (72%)  44  (80%)  35  (78%)  79  (79%)
Found deceased by first responders ----  24  (44%)  15  (33%)  39  (39%)
Manner of death (suspected or confirmed)
Accident  456  (91%)  51  (93%)  42  (93%)  93  (93%)
Suicide  33  (7%)  1  (2%)  3  (7%)  4  (4%)
Undetermined  12  (2%)  1  (2%)  0  (0%)  1  (1%)
Naloxone administration  74  (15%)  14  (25%)  14  (31%)  28  (28%)
Bystander only administered  11  (2%)  1  (2%)  1  (2%)  2  (2%)
Law enforcement only administered  8  (2%)  3  (5%)  1  (2%)  4  (4%)
EMS only administered  42  (8%)  7  (13%)  11  (24%)  18  (18%)
EMS and law enforcement administered  4  (1%)  2  (4%)  0  (0%)  2  (2%)
EMS and bystander administered  9  (2%)  1  (2%)  1  (2%)  2  (2%)
Table 4 displays the overall pattern of the most prominent drug categories identified in 
confirmed overdoses. As expected, nonpharmaceutical fentanyl is the most frequent cause of 
death to date in 2021, at 74%, 7% higher than in 2020. Heroin involvement has been declining 
during the last several years; it represents only 10% of 2021 deaths. Illicit stimulants have been 
increasing in recent years, and in January and February cocaine-involved fatalities constituted 
27% of cases and methamphetamine 23%. Amphetamine is a metabolite of methamphetamine, 
and is frequently found with it. Fentanyl is found in combination with cocaine in 16% of cases, 
and fentanyl and methamphetamine as a combination in 20%. Pharmaceutical opioids were 
identified as a cause of death in 23% of cases, all in combination with other drugs.
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Table 4. Key drug categories and combinations causing death among confirmed overdoses
Cause of death (alone or in  
combination with other drugs)
Jan–Dec 2020  
Est. N=503








Fentanyl or fentanyl analogs   337   (67%)   39   (72%)   21   (78%)   60   (74%)
Heroin   53   (11%)   5   (9%)   3   (11%)   8   (10%)
Nonpharmaceutical stimulants
Cocaine   119   (24%)   17   (31%)   5   (19%)   22   (27%)
Methamphetamine/amphetamine   102   (20%)   11   (20%)   4   (15%)   19   (23%)
Pharmaceutical opioids   119   (24%)   15   (28%)   4   (15%)   19   (23%)
Key combinations
Fentanyl and cocaine   97   (19%)   9   (17%)   4   (15%)   13   (16%)
Fentanyl and methamphetamine/ 
amphetamine
  72   (14%)   12   (22%)   4   (15%)   16   (20%)
Nonfatal Overdoses
We do not have a precise way to calculate nonfatal overdoses. Several metrics can be used to 
estimate minimum numbers of nonfatal overdoses from different perspectives (see Table 5). 
This includes, for example, counting the number of responses by EMS in which the EMT or 
paramedic suspects an overdose and administers naloxone. However, many persons involved 
with an overdose event do not call 911. One syringe access program in Maine estimates that 
as many as 74% of overdose events do not include a 911 call. Put another way, the 911 calls may 
represent only 26% of the overdoses, whereas 74% constitute “private overdoses.” Some of these 
persons will unfortunately die. In about 15% of EMS overdose cases, the patient is revived, but 
refuses to be transported to the emergency room. Some may receive naloxone, but are found 
later not have had an overdose, but were unconscious or had stopped breathing for another 
reason.
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Table 5. Five partially overlapping metrics estimating the number of nonfatal overdoses per 
month









based on  
Jan–Feb 2021
Number of EMS runs in which naloxone was administered and patient 
survived1
105 74
Number of Emergency Department visits likely involving a drug overdose, 
less those who were transported by EMS and then died2
277 256
Number of overdose reversals reported by community naloxone 
distributors and users of the OD-ME mobile app, minus the number of fatal 
overdoses in which bystanders administered naloxone (163-2=161)3
161 151




1 Maine EMS; Maine Office of Chief Medical Examiner
2 Maine CDC, Syndromic Surveillance
3 Maine Naloxone Distribution Initiative (based on January total); OD-ME mobile app
4 Maine Office of Chief Medical Examiner; ODMAP initiative
Highlight of the Month Regarding  
Substance Use Disorder Public Policy Response
Comprehensive Drug-Related Data Website
Our highlighted project this month is the Opioid Data Sharing Committee and the newly created 
https://mainedrugdata.org website. The Committee will be holding its 8th monthly meeting this month. 
Co-chaired by Rebecca Taylor, Deputy Director of Research and Evaluation at the Office of Behavioral 
Health and Gordon Smith, Director of Opioid Response, and staffed by the University of Maine research 
team, the committee’s purpose is to identify all the potential statewide sources of data on opioids (and 
other drugs as well), analyze the data, and where valuable, work with the source of the data to establish 
regular and timely reporting to the website’s data hub, also managed by the University of Maine. The 
new website will be utilized to publicly report the data, including this new Maine Monthly Overdose 
Report. Since its establishment in mid-January, the website has already attracted approximately 73,000 
“hits,” or website interactions, and about 3,000 unique visitors. The website now includes data from 
over 25 sources.
The Opioid Data Sharing Committee will be featuring one category of the data each month, and 
exploring its relevance and promise for understanding the drug-related issues Maine is facing, e.g. 
law enforcement; judicial systems; corrections; prescription monitoring; treatment; syringe exchange 
program data; naloxone distribution data; and overdose data. The goal is to improve transparency and 
public engagement, as well as to provide a readily accessible source for information needed both by the 
public and by policy makers, supporting Maine’s efforts to make its policy decisions data-driven and 
evidence-based.
